-->

Tech Seeker (TS)

Purdue Pharma LP
Profile last edited on: 6/1/2011

NO Business Identifier is currently available for this company.
TS Type
N/A
Status
Year Founded
1892
Last Involved Year
2019

Key People / Management

  Edward G Angelini --

  Danny Chen --

  James J Dolan -- V.P., Licensing & Busines

  James J Dolan --

  Allen G Downs --

  Richard A Inz --

  Rachel S Kreppel --

  Mike Liu -- Manager, Licensing & Busi

  Megan A Macleod -- Business Research Analyst

  Jacinta Nagler --

  Sue Yao --

Location Information

201 Tresser Boulevard
Stamford, CT 06901-3431
   (203) 588-8000
   www.pharma.com

Public Profile

Purdue Pharma L.P. engages in the research, development, production, sales, and licensing of prescription and non-prescription medicines and hospital products. It offers non-prescription products, which include laxatives for constipation and stool softening; microbicides for antiseptic protection; and nutraceuticals. The company also provides magnesium chloride supplements, active pharmaceutical ingredients, glycerin suppositories, and prescription medicines in the form of tablets and capsules. In addition, it offers educational materials and programs relating to pain management. Further, the company engages in non-clinical drug safety evaluation, formulations, analytical support, and pharmacokinetics/drug metabolism functions. It serves healthcare providers, patients, and caregivers. The company offers its products through distributors in the United States. The company was formerly known as Purdue Frederick Company, Inc. and it changed its name in 1991. Purdue Pharma L.P. was founded in 1892 and is headquartered in Stamford, Connecticut with a research lab in Cranbury, New Jersey. The company has manufacturing facilities in Wilson, North Carolina; Totowa, New Jersey; and Coventry, Rhode Island.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
1,350
Revenue
N/A
Public/Private
Privately Held
Stock Info
---
Received SBIR $$
No

SBIR firms in the news

There are no news available.